Together, these data indicate a complex relationship between cerebrovascular dysfunction in Alzheimer’s disease, likely to involve multiple mediators, which is both dependent and independent of amyloid-β and tau depending on stage of disease. This evidence concerns the gene MAPT and Alzheimer disease.